Lagerstroemia speciosa (L.) Pers., ethanolic leaves extract attenuates dapsone-induced liver inflammation in rats

References

• Abdelkader, N.F., et al., 2020. Ellagic acid attenuates liver toxicity induced by valproic acid in rats. Journal of Pharmacological Sciences, 143 (1), 23–29.
   PubMed Web of Science ®Google Scholar
• Akbulut, S., et al., 2014. Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats. World Journal of Gastroenterology, 20 (29), 10158–10165.
   PubMed Web of Science ®Google Scholar
• Asrani, S.K., et al., 2019. Burden of liver diseases in the world. Journal of Hepatology, 70 (1), 151–171.
   PubMed Web of Science ®Google Scholar
• Bancroft, J. D., and Cook, B. C., 1984. Manual of histological techniques. Edinburgh: Churchill Livingstone, 49–51.
   Google Scholar
• Chougule, M., Padhi, B., and Misra, A., 2008. Development of spray dried liposomal dry powder inhaler of Dapsone. AAPS PharmSciTech, 9 (1), 47–53.
   PubMed Web of Science ®Google Scholar
• Coleman, M.D., 1993. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. British Journal of Dermatology, 129 (5), 507–513.
   PubMed Web of Science ®Google Scholar
• Coleman, M.D., 2001. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. Toxicology, 162 (1), 53–60.
   PubMed Web of Science ®Google Scholar
• Das, A.K., and Jawed, Q., 2014. Drug-induced acute pancreatitis: a rare manifestation of an incomplete "dapsone syndrome". Indian Journal of Pharmacology, 46 (4), 455–457.
   PubMed Web of Science ®Google Scholar
• Devaraj, E., et al., 2020. β-Sitosterol attenuates carbon tetrachloride-induced oxidative stress and chronic liver injury in rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 393 (6), 1067–1075.
   PubMed Web of Science ®Google Scholar
• Devarbhavi, H., et al., 2010. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. The American Journal of Gastroenterology, 105 (11), 2396–2404.
   PubMed Web of Science ®Google Scholar
• Devarbhavi, H., et al., 2017. Features and treatment of dapsone-induced hepatitis, based on analysis of 44 cases and literature review. Clinical Gastroenterology and Hepatology, 15 (11), 1805–1807.
   PubMed Web of Science ®Google Scholar
• Devarbhavi, H., et al., 2018. Drug-induced acute liver failure in children and adults: results of a single-centre study of 128 patients. Liver International, 38 (7), 1322–1329.
   PubMed Web of Science ®Google Scholar
• Devarbhavi, H., et al., 2019. Drug-induced acute-on-chronic liver failure in Asian patients. American Journal of Gastroenterology, 114 (6), 929–937.
   PubMed Web of Science ®Google Scholar
• East, J., and Blanton, L.S., 2012. Symptomatic hyperbilirubinemia secondary to dapsone-induced hemolysis and atazanavir therapy. Antimicrobial Agents and Chemotherapy, 56 (2), 1081–1083.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan, D., 2018. Oxidative stress is bane in chronic liver diseases: clinical and experimental perspective. Arab Journal of Gastroenterology, 19 (2), 56–64.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan, D., 2021. Dapsone-induced hepatic complications: it's time to think beyond methemoglobinemia. Drug and Chemical Toxicology, 44 (3), 330–333.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan, D., and Karthikeyan, S., 2016. Silibinin alleviates N-nitrosodimethylamine-induced glutathione dysregulation and hepatotoxicity in rats. Chinese Journal of Natural Medicines, 14 (1), 40–47.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan, D., Karthikeyan, S., and Vivekanandan, P., 2012. Ameliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats. Environmental Toxicology and Pharmacology, 34 (3), 1004–1013.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan, D., Sokal, E., Karthikeyan, S., and Najimi, M., 2014. Plant derived antioxidants and antifibrotic drugs: past, Present and Future. Journal of Coastal Life Medicine, 2 (9), 738–745.
   Google Scholar
• Ezhilarasan, D., Sokal, E., and Najimi, M., 2018. Hepatic fibrosis: it is time to go with hepatic stellate cell-specific therapeutic targets. Hepatobiliary & Pancreatic Diseases International, 17 (3), 192–197.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan, D., Srilekha, S., and Raghu, R., 2017. HAART and hepatotoxicity. Journal of Applied Pharmaceutical Science, 7 (04), 220–226.
   Google Scholar
• Fabregat, I., et al., 2016. TGF-β signalling and liver disease. The FEBS Journal, 283 (12), 2219–2232.,
   PubMed Web of Science ®Google Scholar
• Fromm, E., and Wittmann, J., 1908. Derivate des p-nitrothiophenols. Berichte Der Deutschen Chemischen Gesellschaft, 41 (2), 2264–2273.
   Google Scholar
• Ghaoui, N., et al., 2020. Update on the use of dapsone in dermatology. International Journal of Dermatology, 59 (7), 787–795.
   PubMed Web of Science ®Google Scholar
• Gupta, A., Agrawal, V.K., and Rao, C.V., 2017. Exploration of analgesic and antiinflammatory potential of Lagerstroemia speciosa. Journal of Applied Pharmaceutical Science, 7 (02), 156–161.
   Google Scholar
• Hassan, H.M., et al., 2020. Suppression of cisplatin-induced hepatic injury in rats through alarmin high-mobility group box-1 pathway by Ganoderma lucidum: theoretical and experimental study. Drug Design, Development and Therapy, 14, 2335–2353.
   PubMed Web of Science ®Google Scholar
• Hoofnagle, J.H., and Björnsson, E.S., 2019. Drug-induced liver injury - types and phenotypes. Reply. The New England Journal of Medicine, 381 (14), 1396.
   PubMed Web of Science ®Google Scholar
• Ikeda, Y., Chen, J.T., and Matsuda, T., 1999. Effectiveness and safety of banabamin tablet containing extract from banaba in patients with mild type-2 diabetes. Japanese Pharmacology & Therapeitics, 27, 829–835.
   Google Scholar
• Irshaid, Y., et al., 1994. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 22 (1), 161–164.
   PubMed Web of Science ®Google Scholar
• Itha, S., et al., 2003. Dapsone induced cholangitis as a part of dapsone syndrome: a case report. BMC Gastroenterology, 3, 21.
   PubMed Web of Science ®Google Scholar
• Jayakumar, K.S., et al., 2014. Corosolic acid content and SSR markers in Lagerstroemia speciosa (L.) Pers.: a comparative analysis among populations across the Southern Western Ghats of India. Phytochemistry, 106, 94–103.
   PubMed Web of Science ®Google Scholar
• Keerty, D., Eaton, K., and Haynes, E., 2020. Dapsone-induced hypoxia. Cureus, 12 (7), e9334.
   PubMed Web of Science ®Google Scholar
• Kirby, B., et al., 1999. Abnormal liver function tests induced by dapsone in a patient with dermatitis herpetiformis and primary sclerosing cholangitis. The British Journal of Dermatology, 141 (1), 172–173.
   PubMed Web of Science ®Google Scholar
• Lee, H.C., et al., 2019. Escin protects against acetaminophen-induced liver injury in mice via attenuating inflammatory response and inhibiting ERK signaling pathway. American Journal of Translational Research, 11 (8), 5170–5182.
   PubMed Web of Science ®Google Scholar
• Lewis, J.S., and Jacobs, Z.G., 2020. Subtle case of dapsone-induced methaemoglobinaemia. BMJ Case Reports, 13 (8), e235403.
   PubMedGoogle Scholar
• Licata, A., 2016. Adverse drug reactions and organ damage: the liver. European Journal of Internal Medicine, 28, 9–16.
   PubMed Web of Science ®Google Scholar
• Liu, T., et al., 2017. NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy, 2 (1), 17023.
   PubMed Web of Science ®Google Scholar
• Luedde, T., and Schwabe, R.F., 2011. NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nature Reviews. Gastroenterology & Hepatology, 8 (2), 108–118.
   PubMed Web of Science ®Google Scholar
• Misra, H.P., and Fridovich, I., 1972. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological Chemistry, 247 (10), 3170–3175.
   PubMed Web of Science ®Google Scholar
• Moron, M.S., Depierre, J.W., and Mannervik, B., 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta, 582 (1), 67–78.
   PubMed Web of Science ®Google Scholar
• Mosedale, M., and Watkins, P.B., 2017. Drug-induced liver injury: advances in mechanistic understanding that will inform risk management. Clinical Pharmacology and Therapeutics, 101 (4), 469–480.
   PubMed Web of Science ®Google Scholar
• Mousa, A.M., et al., 2019. Lagerstroemia speciosa (L.) Pers leaf extract attenuates lung tumorigenesis via alleviating oxidative stress. Biomolecules, 9 (12), 871.
   PubMed Web of Science ®Google Scholar
• Norman, B.H., 2020. Drug Induced Liver Injury (DILI). Mechanisms and medicinal chemistry avoidance/mitigation strategies. Journal of Medicinal Chemistry, 63 (20), 11397–11419.
   PubMed Web of Science ®Google Scholar
• Ohkawa, H., Ohishi, N., and Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95 (2), 351–358.
   PubMed Web of Science ®Google Scholar
• Prasad, P., 2000. A study of dapsone syndrome at a rural teaching hospital in South India. Indian Journal of Dermatology, Venereology, 66 (3), 136–138.
   Google Scholar
• Priya, T.T., Sabu, M.C., and Jolly, C.I., 2008. Free radical scavenging and anti-inflammatory properties of Lagerstroemia speciosa (L). Inflammopharmacology, 16 (4), 182–187.
   PubMedGoogle Scholar
• Quaresma, M.V., et al., 2015. Dapsone in the treatment of pemphigus vulgaris: adverse effects and its importance as a corticosteroid sparing agent. Anais Brasileiros de Dermatologia, 90 (3 Suppl 1), 51–54.
   PubMed Web of Science ®Google Scholar
• Rohit Singh, T., and Ezhilarasan, D., 2020. Ethanolic extract of Lagerstroemia speciosa (L.) Pers., induces apoptosis and cell cycle arrest in HepG2 cells. Nutrition and Cancer, 72 (1), 146–156.
   PubMed Web of Science ®Google Scholar
• Saumya, S.M., and Basha, P.M., 2011. Antioxidant effect of Lagerstroemia speciosa Pers (banaba) leaf extract in streptozotocin-induced diabetic mice. Indian Journal of Experimental Biology, 49 (2), 125–131.
   PubMed Web of Science ®Google Scholar
• Schwabe, R.F., and Brenner, D.A., 2006. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. American Journal of Physiology. Gastrointestinal and Liver Physiology, 290 (4), G583–G589.
   PubMed Web of Science ®Google Scholar
• Semira , Wafai, Z.A., et al., 2014. Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria. Indian Journal of Pharmacology, 46 (4), 438–440.
   PubMed Web of Science ®Google Scholar
• Sharmin, T., Rahman, M.S., and Mohammadi, H., 2018. Investigation of biological activities of the flowers of Lagerstroemia speciosa, the Jarul flower of Bangladesh. BMC Complementary and Alternative Medicine, 18 (1), 231.
   PubMed Web of Science ®Google Scholar
• Stohs, S.J., Miller, H., and Kaats, G.R., 2012. A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid. Phytotherapy Research : PTR, 26 (3), 317–324.
   PubMed Web of Science ®Google Scholar
• Takahara, S., et al., 1960. Hypocatalasemia: a new genetic carrier state. The Journal of Clinical Investigation, 39, 610–619.
   PubMed Web of Science ®Google Scholar
• Thakur, R.S., and Devaraj, E., 2020. Lagerstroemia speciosa (L.) Pers. triggers oxidative stress mediated apoptosis via intrinsic mitochondrial pathway in HepG2 cells. Environmental Toxicology, 35 (11), 1225–1233.
   PubMed Web of Science ®Google Scholar
• Tiwary, B.K., et al., 2017. Radical Scavenging Activities of Lagerstroemia speciosa (L.) Pers. Petal Extracts and its hepato-protection in CCl4-intoxicated mice. BMC Complementary and Alternative Medicine, 17 (1), 55.
   PubMed Web of Science ®Google Scholar
• Unno, T., et al., 1997. Antioxidative activity of water extracts of Lagerstroemia speciosa leaves. Bioscience, Biotechnology, and Biochemistry, 61 (10), 1772–1774.
   PubMed Web of Science ®Google Scholar
• Veggi, L.M., et al., 2002. Dapsone-induced cholestasis and impairment of bile salt output in the rat. Biochemical Pharmacology, 63 (8), 1553–1563.
   PubMed Web of Science ®Google Scholar
• Veggi, L.M., et al., 2005. Dapsone impairs the bile salt-independent fraction of bile flow in rats: possible involvement of its N-hydroxylated metabolite. Toxicology, 211 (1–2), 97–106.
   PubMed Web of Science ®Google Scholar
• Veggi, L. M., et al., 2008. Dapsone induces oxidative stress and impairs antioxidant defenses in rat liver. Life Sciences, 83 (5-6), 155–163.
   PubMed Web of Science ®Google Scholar
• Vinod, K.V., Arun, K., and Dutta, T.K., 2013. Dapsone hypersensitivity syndrome: a rare life threatening complication of dapsone therapy. Journal of Pharmacology & Pharmacotherapeutics, 4 (2), 158–160.
   PubMedGoogle Scholar
• Wozel, G., and Blasum, C., 2014. Dapsone in dermatology and beyond. Archives of Dermatological Research, 306 (2), 103–124.
   PubMed Web of Science ®Google Scholar
• Zhang, J.X., et al., 2020. Corosolic acid attenuates hepatic lipid accumulation and inflammatory response via AMPK/SREBPs and NF-κB/MAPK signaling pathways. The American Journal of Chinese Medicine, 48 (3), 579–595.
   PubMed Web of Science ®Google Scholar
• Zhu, Y.I., and Stiller, M.J., 2001. Dapsone and sulfones in dermatology: overview and update. Journal of the American Academy of Dermatology, 45 (3), 420–434.
   PubMed Web of Science ®Google Scholar